{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:59:17Z","timestamp":1773349157873,"version":"3.50.1"},"reference-count":38,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>We assessed the prevalence of patients with ankylosing spondylitis (AS), rating their state as acceptable (patient-acceptable symptom state; PASS), among 190 patients with AS seen in daily practice. Factors associated with PASS status and PASS thresholds for outcome measures were also analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>The characteristics of patients with affirmative and negative assignment to PASS were compared. Associated factors were estimated by logistic regression models and PASS thresholds by the 75th percentile and receiver-operating characteristic curve methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>A total of 77% of patients rated their state as acceptable (95% CI 62\u201391). These patients were taking fewer nonsteroidal antiinflammatory drugs and corticosteroids, practiced more exercise, had less anxiety and depression, and had lower values of all patient-reported outcome measures, physicians\u2019 assessment, AS Disease Activity Score (ASDAS) and C-reactive protein. Lower values of Bath AS Disease Activity Index and physician\u2019s global assessment were independent factors associated with acceptable symptom state. High rates of anxiety and depression were found in patients not in PASS. The thresholds with the 75th percentile approach were 4.55 for the BASDAI and 2.84 for the ASDAS. Fifty-three percent of patients in PASS had a high or very high disease activity state according to ASDAS cutoff values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>A high percentage of patients with AS in daily practice declared that their symptom state was acceptable. PASS status correlated with physician global assessment and BASDAI. PASS thresholds for common recommended outcome measures were relatively high and many patients in PASS had unacceptably high disease activity states according to ASDAS. Other factors such as psychological problems may influence a negative PASS state.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.111481","type":"journal-article","created":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T03:06:23Z","timestamp":1338606383000},"page":"1424-1432","source":"Crossref","is-referenced-by-count":16,"title":["Patient-acceptable Symptom State as an Outcome Measure in the Daily Care of Patients with Ankylosing Spondylitis"],"prefix":"10.3899","volume":"39","author":[{"given":"CARLOS","family":"RODR\u00cdGUEZ-LOZANO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAR\u00cdA-\u00c1NGELES","family":"GANTES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BEATRIZ","family":"GONZ\u00c1LEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOS\u00c9 A.","family":"HERN\u00c1NDEZ-BERIAIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONIO","family":"NARANJO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VANESA","family":"HERN\u00c1NDEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN C.","family":"QUEVEDO-ABELEDO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. JOS\u00c9","family":"FALC\u00d3N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SERGIO","family":"MACH\u00cdN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIGUEL A.","family":"DESCALZO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2012,6,1]]},"reference":[{"key":"2018112909280235000_39.7.1424.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.019224"},{"key":"2018112909280235000_39.7.1424.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11197"},{"key":"2018112909280235000_39.7.1424.3","first-page":"2225","article-title":"Preliminary core sets for endpoints in ankylosing spondylitis","volume":"24","author":"Van der Heijde","year":"1997","journal-title":"J Rheumatol"},{"key":"2018112909280235000_39.7.1424.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.20790"},{"key":"2018112909280235000_39.7.1424.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018"},{"key":"2018112909280235000_39.7.1424.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094870"},{"key":"2018112909280235000_39.7.1424.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100826"},{"key":"2018112909280235000_39.7.1424.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138594"},{"key":"2018112909280235000_39.7.1424.9","first-page":"2025","article-title":"Minimal clinically important difference, low disease activity state and patient acceptable symptom state: Methodological issues","volume":"32","author":"Tubach","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909280235000_39.7.1424.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22110"},{"key":"2018112909280235000_39.7.1424.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.023028"},{"key":"2018112909280235000_39.7.1424.12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.2007.079798","article-title":"Minimal clinically important improvement\/difference (MCII\/MCID) and patient acceptable symptom state (PASS): What do these concepts mean?","volume":"66","author":"Kvien","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2018112909280235000_39.7.1424.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.22469"},{"key":"2018112909280235000_39.7.1424.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.23527"},{"key":"2018112909280235000_39.7.1424.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.22342"},{"key":"2018112909280235000_39.7.1424.16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/acr.20131","article-title":"Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics","volume":"62","author":"Maksymowych","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2018112909280235000_39.7.1424.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"2018112909280235000_39.7.1424.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.20"},{"key":"2018112909280235000_39.7.1424.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2018112909280235000_39.7.1424.20","doi-asserted-by":"publisher","DOI":"10.1348\/014466501163904"},{"key":"2018112909280235000_39.7.1424.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1699-258X(06)73024-8"},{"key":"2018112909280235000_39.7.1424.22","first-page":"1188","article-title":"Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders","volume":"34","author":"Tubach","year":"2007","journal-title":"J Rheumatol"},{"key":"2018112909280235000_39.7.1424.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.127"},{"key":"2018112909280235000_39.7.1424.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem084"},{"key":"2018112909280235000_39.7.1424.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090449"},{"issue":"Suppl","key":"2018112909280235000_39.7.1424.26","first-page":"1786","article-title":"Achievement of a patient acceptable symptom state (PASS) and of a minimum clinically important improvement (MCII) with etanercept in refractory heel enthesitis related to spondyloarthritis: Results of a double blind placebo controlled study (HEEL) [abstract]","volume":"60","author":"Dougados","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2018112909280235000_39.7.1424.27","first-page":"1883","article-title":"Predictive factors for the long-term outcome of spondyloarthropathies","volume":"21","author":"Amor","year":"1994","journal-title":"J Rheumatol"},{"key":"2018112909280235000_39.7.1424.28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.7.766"},{"key":"2018112909280235000_39.7.1424.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep174"},{"key":"2018112909280235000_39.7.1424.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(01)00296-3"},{"key":"2018112909280235000_39.7.1424.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel115"},{"key":"2018112909280235000_39.7.1424.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh595"},{"key":"2018112909280235000_39.7.1424.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077503"},{"key":"2018112909280235000_39.7.1424.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.23275"},{"key":"2018112909280235000_39.7.1424.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.21054"},{"issue":"Suppl","key":"2018112909280235000_39.7.1424.36","first-page":"65","article-title":"Disease activity over one year in early ankylosing spondylitis in a prospective observational cohort (GESPIC) [abstract]","volume":"64","author":"Rudwaleit","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2018112909280235000_39.7.1424.37","first-page":"CD002822","article-title":"Physiotherapy interventions for ankylosing spondylitis","volume":"1","author":"Dagfinrud","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2018112909280235000_39.7.1424.38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh595"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.111481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:17:35Z","timestamp":1543515455000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.111481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,1]]},"published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.3899\/jrheum.111481"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.111481","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,1]]}}}